Terms: = Sarcomas AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
15 results:
1. Histiocytic sarcoma following car T-cell therapy: a case report.
An K; He Y; Tang Y; Gu X; Qian J; Li B
Int J Hematol; 2024 Mar; 119(3):338-341. PubMed ID: 38294639
[TBL] [Abstract] [Full Text] [Related]
2. Glomus Tumor of the Lower Extremity Previously Misdiagnosed as Complex Regional Pain Syndrome in Close Proximity to a Myxofibrosarcoma: A Case Report.
Nazemi AK; Grossi J; Tavernier FB; Boyce BF; Komatsu DE; Khan FA
J Am Acad Orthop Surg Glob Res Rev; 2022 Jul; 6(7):. PubMed ID: 35797605
[TBL] [Abstract] [Full Text] [Related]
3. ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights.
Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
[TBL] [Abstract] [Full Text] [Related]
4. Thorahcic SMARCA4-deficient undifferentiated tumors with ganglioneuroma and enchondroma: implications for SLC7A11 and ARID1A expression: a case report.
Kito Y; Kawashima K; Saigo C; Hasegawa M; Nomura S; Mikamo T; Hanamatsu Y; Matsuo Y; Takeuchi T
Diagn Pathol; 2022 Feb; 17(1):29. PubMed ID: 35151345
[TBL] [Abstract] [Full Text] [Related]
5. Superficial Angiomyxomas Frequently Demonstrate Loss of Protein Kinase A Regulatory Subunit 1 Alpha Expression: Immunohistochemical Analysis of 29 Cases and Cutaneous Myxoid Neoplasms With Histopathologic Overlap.
Neumann NM; LeBoit PE; Cohen JN
Am J Surg Pathol; 2022 Feb; 46(2):226-232. PubMed ID: 34889853
[TBL] [Abstract] [Full Text] [Related]
6. CD56-chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report.
Jiang C; Zhao W; Qin M; Jin M; Chang L; Ma X
Medicine (Baltimore); 2019 Oct; 98(43):e17572. PubMed ID: 31651858
[TBL] [Abstract] [Full Text] [Related]
7. Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and carney Complex).
Jouinot A; Bertherat J
Exp Suppl; 2019; 111():149-169. PubMed ID: 31588532
[TBL] [Abstract] [Full Text] [Related]
8. [RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : sarcomes rétropéritonéaux French ccAFU guidelines — Update 2018—2020: Retroperitoneal sarcoma].
Murez T; Savoie PH; Fléchon A; Durand X; Rocher L; Camparo P; Morel-Journel N; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2018 Nov; 28(12S):S165-S174. PubMed ID: 30473000
[TBL] [Abstract] [Full Text] [Related]
9. Cancer-associated retinopathy preceding the diagnosis of cancer.
Hoogewoud F; Butori P; Blanche P; Brézin AP
BMC Ophthalmol; 2018 Nov; 18(1):285. PubMed ID: 30390655
[TBL] [Abstract] [Full Text] [Related]
10. Immune-related Adverse Events in Cancer Patients.
Pallin DJ; Baugh CW; Postow MA; Caterino JM; Erickson TB; Lyman GH
Acad Emerg Med; 2018 Jul; 25(7):819-827. PubMed ID: 29729100
[TBL] [Abstract] [Full Text] [Related]
11. Socio-economic patterning in early mortality of patients aged 0-49 years diagnosed with primary bone cancer in Great Britain, 1985-2008.
Blakey K; Feltbower RG; James PW; Libby G; Stiller C; Norman P; Gerrand C; McNally RJQ
Cancer Epidemiol; 2018 Apr; 53():49-55. PubMed ID: 29414632
[TBL] [Abstract] [Full Text] [Related]
12. Surgical treatment of a Morel-Lavallée lesion of the distal thigh with the use of lymphatic mapping and fibrin sealant.
Jones RM; Hart AM
J Plast Reconstr Aesthet Surg; 2012 Nov; 65(11):1589-91. PubMed ID: 22552264
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of quality of life after amputation or limb salvage.
Refaat Y; Gunnoe J; Hornicek FJ; Mankin HJ
Clin Orthop Relat Res; 2002 Apr; (397):298-305. PubMed ID: 11953621
[TBL] [Abstract] [Full Text] [Related]
14. The monoclonal antibody-defined car-3 antigen is a serological marker associated with pancreatic carcinoma.
Prat M; Medico E; Piantino P; Bretti S; Rossini FP; Comoglio PM
Int J Biol Markers; 1988; 3(1):29-35. PubMed ID: 2977786
[TBL] [Abstract] [Full Text] [Related]
15. car-3, a monoclonal antibody-defined antigen expressed on human carcinomas.
Prat M; Morra I; Bussolati G; Comoglio PM
Cancer Res; 1985 Nov; 45(11 Pt 2):5799-807. PubMed ID: 2413998
[TBL] [Abstract] [Full Text] [Related]
